Prescription GLP-1

Saxenda: Breakthrough Treatment for Chronic Weight Management

Prescribed worldwide, Saxenda empowers eligible adults and teens struggling with obesity to achieve long-term, clinically proven weight reduction—when lifestyle changes alone aren't enough.

E
Evidence-Based

Backed by robust clinical trials, Saxenda demonstrates statistically significant weight loss in adults and teens with chronic obesity.

S
Self-Administered

The simple, once-daily injection pen is designed for safe use at home, with detailed guidance from your healthcare provider.

A
Appetite Regulation

Saxenda works by mimicking a natural hormone, helping reduce hunger, increase fullness, and improve adherence to reduced-calorie diets.

C
Cardiometabolic Impact

Alongside weight loss, Saxenda has shown positive effects on blood pressure, cholesterol, and certain metabolic risk factors.

FDA Approved Since 2014

What Is Saxenda and How Does It Work?

Saxenda (liraglutide 3 mg) is a prescription medication used for chronic weight management in adults with obesity or overweight and at least one weight-related medical condition (such as hypertension, type 2 diabetes, or dyslipidemia). It is also approved for adolescents (12-17 years old) with a body weight above 60 kg and obesity.

As a member of the GLP-1 receptor agonist class, Saxenda mimics the function of the naturally occurring hormone glucagon-like peptide-1. This hormone helps regulate appetite and calorie intake by signaling satiety to the brain and slowing stomach emptying. Saxenda is administered once daily via a prefilled injection pen, typically into the abdomen, thigh, or upper arm, making it convenient for at-home use.

Who Is Saxenda For?

  • Adults with a Body Mass Index (BMI) of ≥30 kg/m² (obesity), or ≥27 kg/m² (overweight) plus at least one weight-related condition.
  • Adolescents aged 12-17 with obesity and body weight over 60kg, requiring specialist supervision.
  • Those who have struggled to maintain weight loss with diet and physical activity alone.

Saxenda is not for everyone. It is not indicated for use as a general weight loss medication in people who do not meet these criteria, and is not recommended for patients with a personal or family history of certain rare endocrine tumors, or a history of pancreatitis.

What’s It Like to Use Saxenda?

Most patients start Saxenda at a low dose (0.6 mg per day) and gradually titrate up to the full 3 mg dose over several weeks to minimize gastrointestinal side effects. In our clinic, we’ve found patients appreciate the pen’s intuitive design and needle concealment, with most mastering self-injection after one or two demonstrations.

The injection is quick—typically less than 30 seconds. Some patients report mild nausea, especially during the early weeks. However, this tends to resolve as the body adjusts. Consistency is key: Saxenda works best as part of a structured weight management plan, including regular activity and dietary changes.

How Effective Is Saxenda?

In randomized clinical trials (such as SCALE and its adolescent counterpart), patients using Saxenda alongside a reduced-calorie diet and increased physical activity achieved on average 5% to 10% weight reduction over 56 weeks—significantly more than those using placebo. Those achieving at least 5% weight loss at week 16 are most likely to achieve greater, sustained results.

  • Average weight loss: 8.4% of initial body weight in adults after a year
  • One in three adult patients achieved at least 10% weight loss
  • Similar efficacy has been observed in teens, with an average loss of nearly 12 lbs (5.5 kg)

It’s important to note that weight regain may occur if Saxenda is discontinued, so ongoing support is recommended.

How Does Saxenda Compare to Other Medications?

While drugs like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) offer even greater average weight loss, Saxenda remains a leading option where newer medications may not be accessible or suitable. Unlike oral weight loss drugs, Saxenda's injectable delivery ensures full absorption and predictable effects. For patients new to GLP-1 therapies, Saxenda offers proven, incremental results with a well-understood safety profile. See our full comparison of weight loss medications.

What Are the Side Effects?

  1. Nausea (common, especially during dose escalation)
  2. Vomiting or diarrhea (mild, transient in most cases)
  3. Constipation
  4. Injection site reactions (redness, pain, or swelling)
  5. Rare but serious: pancreatitis, gallbladder disease, or kidney problems

The safety profile of Saxenda is well documented and discussed at every appointment. Most side effects improve with time and careful dose titration. Serious risks are rare but require immediate medical attention—your provider will discuss these and monitor for them.

How Do I Get Started with Saxenda?

  • Consult with a healthcare professional to determine eligibility.
  • Review your full medical history for contraindications.
  • Obtain a prescription and demonstration in clinic or pharmacy.
  • Ongoing follow-up to monitor progress and adjust your plan as needed.

While Saxenda is typically covered by insurance for those meeting clinical criteria, out-of-pocket costs may vary. Savings programs and patient assistance may be available. For further guidance, see our guide on prescription weight loss drugs.

5-10%
Average Weight Loss (1 year)
2014
FDA Approval Year
12-17
Approved Age Range (Adolescents)
+60kg
Minimum Weight for Teens

Frequently Asked Questions about Saxenda

Most patients begin to notice appetite suppression within the first week. Clinically meaningful weight loss (≥5%) is typically achieved after 12–16 weeks of continuous use, provided Saxenda is combined with diet and activity changes. Those who do not reach 4% weight loss by week 16 are less likely to benefit with continued use.
If you miss a dose and it’s been less than 12 hours since your usual time, take it as soon as you remember. If more than 12 hours have passed, skip the missed dose and resume your usual schedule the next day. Do not double up doses. If you miss more than three days, consult your provider about restarting at a lower dose to minimize side effects.
Weight regain is common if Saxenda is discontinued without ongoing support, as appetite returns to baseline and caloric intake may increase. Long-term lifestyle changes and, in some cases, transition to other therapies are critical to maintaining weight loss results.
Saxenda has not been studied in combination with other prescription weight loss medications. Combining therapies may increase risks without enhancing benefits. Always consult your healthcare provider before taking Saxenda with other anti-obesity drugs or diabetes medications.
Coverage varies by plan. Many commercial insurers and some Medicaid programs cover Saxenda for patients meeting strict criteria. Prior authorization is usually required. Manufacturer savings cards or patient assistance may help with out-of-pocket costs in eligible cases.

Ready to Take the Next Step with Saxenda?

Join thousands who have regained control over their health. Secure your consultation—timely support makes all the difference in long-term results.

Find a Provider